Humana (NYSE:HUM) experienced a 3% price increase last week, which may have been influenced by its recent partnership with Mercy to open new primary care clinics for seniors. This expansion addresses ...

Jefferies analysts lowered the price target on Humana (NYSE:HUM) stock to $244.00 from $287.00 on Wednesday ... with insights into the company’s strategic positioning and market performance. This ...

CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. Read why CVS ...

Molina Healthcare provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare ...

Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $84.00. The company’s shares closed yester ...

Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.

Insurance companies are cautiously optimistic about the Trump administration’s policies for their industry: insurers saw ...

Shares of Humana Inc. HUM rose 1.39% to $234.96 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.38% to 6,045.26 and the ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...